Evidence map›Paper›PMID 37495250›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2023

Innovative three-dimensional models for understanding mechanisms underlying lung diseases: powerful tools for translational research.

Mehmet Nizamoglu, Mugdha M Joglekar, Catarina R Almeida, Anna-Karin Larsson Callerfelt, Isabelle Dupin, Olivier T Guenat, Pauline Henrot, Lisette van Os, Jorge Otero, Linda Elowsson and 2 more

Open access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Tools of the trade: leveraging 3DFrontiers in pharmacology · 2026
    Review
  5. Article
  6. Altered Metabolism in Idiopathic Pulmonary Fibrosis.Journal of cellular physiology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Physiological Modeling of the Vascularized Human Lung Organoid.American journal of respiratory cell and molecular biology · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Generation of Human 3D Airway Assembloids for Advanced Modeling.International journal of biological sciences · 2025
    Article
  18. Lung stem cells and respiratory epithelial chimerism in transplantation.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  19. Review
  20. A novelThe European respiratory journal · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 6 countries.

Mehmet NizamogluUniversity of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands.ORCID https://orcid.org/0000-0002-3663-4107
Mugdha M JoglekarUniversity of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands.
Catarina R AlmeidaDepartment of Medical Sciences, Institute of Biomedicine (iBiMED), University of Aveiro, Aveiro, Portugal.
Anna-Karin Larsson CallerfeltLung Biology, Department of Experimental Medical Science, Lund University, Lund, Sweden.
Isabelle DupinCentre de Recherche Cardio-thoracique de Bordeaux, Université de Bordeaux, Pessac, France.ORCID https://orcid.org/0000-0002-4992-9625
Olivier T GuenatOrgans-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research, University of Bern, Bern, Switzerland.
Pauline HenrotCentre de Recherche Cardio-thoracique de Bordeaux, Université de Bordeaux, Pessac, France.
Lisette van OsOrgans-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research, University of Bern, Bern, Switzerland.
Jorge OteroUnit of Biophysics and Bioengineering, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Linda ElowssonLung Biology, Department of Experimental Medical Science, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0002-0457-0188
Ramon FarreUnit of Biophysics and Bioengineering, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Janette K BurgessUniversity of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands j.k.burgess@umcg.nl.ORCID https://orcid.org/0000-0001-9868-9966
University Medical Center Groningen · NLCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESLund University · SEUniversité de Bordeaux · FRUniversity of Bern · CHUniversity of Aveiro · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic lung diseases result from alteration and/or destruction of lung tissue, inevitably causing decreased breathing capacity and quality of life for patients. While animal models have paved the way for our understanding of pathobiology and the development of therapeutic strategies for disease management, their translational capacity is limited. There is, therefore, a well-recognised need for innovative

Indexed as

Lung DiseasesTranslational Research, BiomedicalAnimalsHumansLungQuality of Life

Identifiers

PMID37495250
PMCPMC10369168
OpenAlexW4385295423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.